相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Features and outcome of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry
Adalet Meral Gunes et al.
PEDIATRIC BLOOD & CANCER (2021)
Systematic Review of Normal Subjects Harbouring BCR-ABL1 Fusion Gene
Jew Win Kuan et al.
ACTA HAEMATOLOGICA (2020)
Bleeding signs due to acquired von Willebrand syndrome at diagnosis of chronic myeloid leukaemia in children
Ralf Knoefler et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
A. Hochhaus et al.
LEUKEMIA (2020)
Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission
Katerina Machova Polakova et al.
LEUKEMIA (2020)
Vaccination With Live Attenuated Vaccines in Four Children With Chronic Myeloid Leukemia While on Imatinib Treatment
Claudia Bettoni da Cunha-Riehm et al.
FRONTIERS IN IMMUNOLOGY (2020)
Imatinib-Induced Hypogammaglobulinemia in Children and Adolescents with Chronic Myeloid Leukemia
Sidharth Totadri et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2020)
Is cancer latency an outdated concept? Lessons from chronic myeloid leukemia
Manuel Abecasis et al.
LEUKEMIA (2020)
Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study
Deborah Meyran et al.
EUROPEAN JOURNAL OF CANCER (2020)
Prognostic Significance of Transcript-Type BCR-ABL1 in Chronic Myeloid Leukemia
Matteo Molica et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2020)
Stuttering Priapism in a Teenage Boy
Pallavi Sachdeva et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2020)
Horn of plenty: Value of the international registry for pediatric chronic myeloid leukemia
Meinolf Suttorp et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2020)
Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia
Shady Adnan Awad et al.
BLOOD ADVANCES (2020)
Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry)
Susanne Moebius et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Chronic Myeloid Leukemia as Secondary Malignancy Following the Treatment of Hodgkin Lymphoma: A Case Series
Ralph Millett et al.
ANTICANCER RESEARCH (2019)
Favourable outcome of de novo advanced phases of childhood chronic myeloid leukaemia
Frederic Millot et al.
EUROPEAN JOURNAL OF CANCER (2019)
Large amplicon droplet digital PCR for DNA-based monitoring of pediatric chronic myeloid leukaemia
Manuela Krumbholz et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia
Susan Branford et al.
LEUKEMIA (2019)
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group
Uma Athale et al.
PEDIATRIC BLOOD & CANCER (2019)
Chronic myeloid leukemia: the concepts of resistance and persistence and the relationship with the BCR-ABL1 transcript type
Michele Baccarani et al.
LEUKEMIA (2019)
High Platelet Counts, Thrombosis, Bleeding Signs, and Acquired Von Willebrand Syndrome at Diagnosis of Pediatric Chronic Myeloid Leukemia
Meinolf Suttorp et al.
BLOOD (2019)
The Hidden Pathogenesis of CML: Is BCR-ABL1 the First Event?
Naranie Shanmuganathan et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2019)
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview
Michele Baccarani et al.
LEUKEMIA (2019)
Meeting the needs of CML patients in resource-poor countries
Hemant Malhotra et al.
Hematology-American Society of Hematology Education Program (2019)
Reversal of Glanzmann thrombasthenia platelet phenotype after imatinib treatment in a pediatric chronic myeloid leukemia patient
Richa Chauhan et al.
PLATELETS (2018)
Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options
Steffen Koschmieder et al.
SEMINARS IN CANCER BIOLOGY (2018)
Pharmacology and pharmacokinetics of imatinib in pediatric patients
Meinolf Suttorp et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2018)
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease
Susan Branford et al.
BLOOD (2018)
The underestimated role of basophils in Ph+ chronic myeloid leukaemia
Peter Valent et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
Leukemoid reaction in the pediatric population: etiologies, outcome, and implications
Assaf Hoofien et al.
EUROPEAN JOURNAL OF PEDIATRICS (2018)
Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia
Xin Qing et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2018)
BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia
Ilaria S. Pagani et al.
HAEMATOLOGICA (2018)
Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia
Thomas Ernst et al.
LEUKEMIA (2018)
Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial
Meinolf Suttorp et al.
LEUKEMIA (2018)
Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia
Raquel C. Maia et al.
MOLECULES (2018)
Genomic BCR-ABL1 breakpoint characterization by a multi-strategy approach for “personalized monitoring” of residual disease in chronic myeloid leukemia patients
Cosimo Cumbo et al.
Oncotarget (2018)
BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia
Ilaria S. Pagani et al.
HAEMATOLOGICA (2018)
Chronic Myeloid Leukemia, Version 1.2019 Clinical Practice Guidelines in Oncology
Jerald P. Radich et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Bone Marrow Core Biopsy in 508 Consecutive Patients With Chronic Myeloid Leukemia: Assessment of Potential Value
Juliana E. Hidalgo-Lopez et al.
CANCER (2018)
Priapism as the initial sign in hematologic disease: Case report and literature review
Luis Cuitlahuac Becerra-Pedraza et al.
INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS (2018)
A causal mechanism for childhood acute lymphoblastic leukaemia
Mel Greaves
NATURE REVIEWS CANCER (2018)
Leukostasis retinopathy: An uncommon visual threatening complication of chronic myeloid leukemia with severe hyperleukocytosis - A case report and review of the literature
Bo Chen et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2018)
JMML genomics and decisions
Charlotte M. Niemeyer
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2018)
Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents
Frederic Millot et al.
HAEMATOLOGICA (2017)
Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia
Hanna L. M. Rajala et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)
Increased megakaryocytic proliferation, pro-platelet deposition and expression of fibrosis-associated factors in children with chronic myeloid leukaemia with bone marrow fibrosis
K. Hussein et al.
LEUKEMIA (2017)
Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia
E. Togasaki et al.
BLOOD CANCER JOURNAL (2017)
Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents
Frederic Millot et al.
HAEMATOLOGICA (2017)
Transcriptome Analysis of Monozygotic Twin Brothers with Childhood Primary Myelofibrosis
Nan Ding et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2017)
Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents
Frederic Millot et al.
CANCER (2017)
Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay
Danilo Perrotti et al.
CURRENT DRUG TARGETS (2017)
The chronic myeloid leukemia stem cell: stemming the tide of persistence
Tessa L. Holyoake et al.
BLOOD (2017)
Leukostasis in Children and Adolescents with Chronic Myeloid Leukemia: Japanese Pediatric Leukemia/Lymphoma Study Group
Hidemitsu Kurosawa et al.
PEDIATRIC BLOOD & CANCER (2016)
Making the diagnosis, the tools, and risk stratification: More than just BCR-ABL
Daniel Egan et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Chronic myeloid leukemia: reminiscences and dreams
Tariq I. Mughal et al.
HAEMATOLOGICA (2016)
Optimal management for pediatric chronic myeloid leukemia
Akihiko Tanizawa
PEDIATRICS INTERNATIONAL (2016)
Chronic myeloid leukemia: reminiscences and dreams
Tariq I. Mughal et al.
HAEMATOLOGICA (2016)
Myelodysplastic and myeloproliferative disorders of childhood
Henrik Hasle
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death
Markus Pfirrmann et al.
ANNALS OF HEMATOLOGY (2015)
Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes
C. P. Kratz et al.
BRITISH JOURNAL OF CANCER (2015)
Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia
Simona Soverini et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Leukemoid Reaction - A Tale of 50 Years
Piali Mandal et al.
INDIAN PEDIATRICS (2015)
Mutational profile of childhood myeloproliferative neoplasms
A. Karow et al.
LEUKEMIA (2015)
Chronic Myeloid Leukemia in Children Clinical Findings, Management, and Unanswered Questions
Nobuko Hijiya et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2015)
Differences among young adults, adults and elderly chronic myeloid leukemia patients
F. Castagnetti et al.
ANNALS OF ONCOLOGY (2015)
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV
Lida Kalmanti et al.
ANNALS OF HEMATOLOGY (2014)
Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study
Frederic Millot et al.
BLOOD (2014)
Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia
Tiffany Y. Chang et al.
BLOOD (2014)
Managing children with chronic myeloid leukaemia (CML) Recommendations for the management of CML in children and young people up to the age of 18 years
Josu de la Fuente et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Sex differences in the incidence of chronic myeloid leukemia
Tomas Radivoyevitch et al.
RADIATION AND ENVIRONMENTAL BIOPHYSICS (2014)
BCR-ABL PCR testing in chronic myelogenous leukemia: molecular diagnosis for targeted cancer therapy and monitoring
Martin H. Luu et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2013)
Stem Cell Transplantation in Primary Myelofibrosis of Childhood
Bryan Mitton et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2013)
How I manage priapism in chronic myeloid leukaemia patients
Ryan Rodgers et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Splenic infarction in a child revealing chronic myeloid leukemia
David Drummond et al.
EUROPEAN JOURNAL OF PEDIATRICS (2012)
Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia
Manuela Krumbholz et al.
GENES CHROMOSOMES & CANCER (2012)
Chronic Myeloid Leukemia as a Secondary Malignancy after Lymphoma in a Child. A Case Report and Review of the Literature
Kmira Zahra et al.
ONKOLOGIE (2012)
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
Frederic Millot et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Impact of the type of the BCR-ABL fusion transcript on the molecular response in pediatric patients with chronic myeloid leukemia
Meinolf Suttorp et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006
Ai-Hua Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation
J. Score et al.
LEUKEMIA (2010)
Molecular biology of bcr-abl1-positive chronic myeloid leukemia
Alfonso Quintas-Cardama et al.
BLOOD (2009)
Correlation of BCR/ABL transcript variants with patients' characteristics in childhood chronic myeloid leukaemia
Ronald Adler et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Harmonization of molecular monitoring of CML therapy in Europe
M. C. Mueller et al.
LEUKEMIA (2009)
Phenotype of blasts in chronic myeloid leukemia in blastic phase-Analysis of bone marrow trephine biopsies and correlation with cytogenetics
Alistair G. Reid et al.
LEUKEMIA RESEARCH (2009)
Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials
Susan Branford et al.
BLOOD (2008)
Innovative approaches of targeted therapy for CML of childhood in combination with paediatric haematopoietic SCT
M. Suttorp
BONE MARROW TRANSPLANTATION (2008)
Blood outgrowth endothelial cells from chronic myeloid leukaemia patients are BCR/ABL1 negative
Jasmin Otten et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts
Thomas Burmeister et al.
LEUKEMIA RESEARCH (2008)
Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia
G. Buesche et al.
LEUKEMIA (2007)
Unilateral sudden hearing loss as the first sign of chronic myeloid leukemia
Guel Oezbilen Acar et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2007)
Chronic myeloid leukemia as a secondary malignancy after ALK-positive anaplastic large cell lymphoma
Skylar Alsop et al.
HUMAN PATHOLOGY (2007)
A novel BCR-ABL fusion transcript (e18a2) in a child with chronic myeloid leukemia
V. H. J. van der Velden et al.
LEUKEMIA (2007)
An update on the etiology and diagnostic evaluation of a leukemoid reaction
Vissaria Sakka et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2006)
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Michele Baccarani et al.
BLOOD (2006)
Staging of chronic myeloid leukemia in the imatinib era - An evaluation of the World Health Organization proposal
JE Cortes et al.
CANCER (2006)
Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia
F Millot et al.
PEDIATRICS (2005)
Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics
BJ Fang et al.
BLOOD (2005)
e8a2 BCR-ABL: more frequent than other atypical BCR-ABL variants?
S Demehri et al.
LEUKEMIA (2005)
Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study
MA Champagne et al.
BLOOD (2004)
Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial
G Buesche et al.
LEUKEMIA (2003)
Stem cell transplantation for chronic myeloid leukemia in children
K Cwynarski et al.
BLOOD (2003)
Chronic myeloid leukemia as a secondary neoplasm after anti-cancer radiotherapy: A report of three cases and a brief review of the literature
F Bauduer et al.
LEUKEMIA & LYMPHOMA (2002)
Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia
DJ Barnes et al.
ACTA HAEMATOLOGICA (2002)
The molecular biology of chronic myeloid leukemia
MWN Deininger et al.
BLOOD (2000)
Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells
E Gunsilius et al.
LANCET (2000)
分享论文
